DSC_1024.jpg

Host Restrictions to Viral infection:  From HIV to SARS-CoV-2

Type-I interferon warns cells that an intruder is at the gate.  It is produced by cells that cells have detected a pathogen-associated molecular patter (PAMP) recognized by various intracellular and cell-surface receptors that include toll-like receptors, MAVS and RIG-I.  Cells respond to type-I interferon by inducing the transcription of a large number of interferon-stimulated genes, many of which act to counter the replication of viruses and bacteria.  Many ISGs are well-known but there are others that remain to be discovered.  We have identified several previously unknown ISGs some of which are active against HIV.  Others are active against Zika virus.  One ISG we tested was Viperin, a host factor that is known to restrict the replication of several flaviviruses.  We found that Viperin was highly active against Zika.  Moreover, the toll-like receptor agonist, imiquimod (R848) is an approved drug and a powerful inducer of Viperin.  The results suggests that TLR activation could be a means to treat viral infection that would work quite rapidly to induce an antiviral state that would reduce virus replication in an acutely infected person. 

 

HIV-2 and SIV encode Vpx, a virion-packaged accessory protein that induces the degradation of the host restriction factor SAMHD1, allowing the virus to infect macrophages and DCs. SAMHD1 blocks HIV infection by dephosphorylating the deoxynucleotide triphosphates (dNTPs) of the cell, thereby blocking reverse transcription. When the virus infects a cell, Vpx is released, binds to SAMHD1 in the nucleus and sends it off to the proteasome to be degraded.  For reasons that we still don’t fully understand, HIV-1 doesn’t encode Vpx.  We’re interested to understand how SAMHD1 antiviral activity is regulated by the cell and why some lentiviruses need Vpx while others do not. HIV-1 encodes the related accessory protein, Vpr which is also virion-packaged and forms a complex with an E3 ubiquitin ligase.  Vpr may counteract yet another host restriction and we’re trying to understand how that works.

Prof. Nathaniel R. Landau, PhD

 

Professor, Department of Microbiology

 

Member of the Microbial Pathogenesis Program

Full Bio.

Department of Microbiology

Alexandria Center for Life Science - West Tower

430 East 29th Street
Office Rm. 509, Lab Rm. 524
New York, NY 10016

Nathaniel.Landau@nyulangone.org


Direct Line: (212) 263-9197
Fax: (646) 501-4645

  • Twitter Social Icon

©2019 Landau Lab - Biomedical Research Lab at NYU - New York City